30.04.2015 • News

BASF Trials MDI Precursor Production at Chongqing

BASF has begun trial operations at its 400,000 t/y mononitrobenzene plant at Chongqing, in western China. The new facility will feed the group's integrated MDI complex at the same location. Investment costs for the entire project are pegged at €860 million.

In addition to mononitrobenzene, the site will produce 300,000 t/y of aniline, 400,000 t/y of crude MDI and will also have an MDI splitter with a capacity of 400,000 t/y.

Located in the Chongqing Changshou Chemical Industrial Park, the complex, initially planned to go on stream in 2010, took three and a half years to be approved by Chinese authorities. A planned start-up in 2014 was delayed further by BASF's differences with officials over an increase in gas prices.

MDI is an important component for polyurethanes. BASF is building a new Polyurethane Solutions Systems House at Chongqing.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read